- Take the Leukemia Quiz!
- 15 Cancer Symptoms Women Ignore Slideshow
- Cancer Symptoms Men Ignore Slideshow
What is Onureg, and how does it work?
Onureg is a prescription medicine used for continued treatment of adults with acute myeloid leukemia (AML) who:
- had a first complete remission (CR) following intensive induction chemotherapy with or without recovery of your blood cell counts, and
- who are not able to complete intensive curative therapy.
It is not known if Onureg is safe and effective in children under 18 years of age.
What are the side effects of Onureg?
Onureg can cause serious side effects, including:
- New or worsening low white blood cell counts (neutropenia). New or worsening low white blood cell counts are common but can also be severe during treatment with Onureg. If your white blood cell counts become very low, you are at increased risk for infections. Your healthcare provider will check your white blood cell counts before and during treatment with Onureg. Your healthcare provider may prescribe a medicine to help increase your white blood cell count if needed.
Tell your healthcare provider right away if you get any of the following symptoms:
- New or worsening low platelet counts (thrombocytopenia). Low platelet counts are common but can also be severe during treatment with Onureg. Your healthcare provider will check your platelet counts before and during treatment with Onureg. Tell your healthcare provider right away if you have any unusual bruising or bleeding. Your healthcare provider may change your dose or tell you to stop taking Onureg if you have low blood cell counts.
Onureg may cause fertility problems in males and females, which may affect your ability to have children. Talk with your healthcare provider if you have concerns about fertility.
The most common side effects of Onureg include:
- nausea and vomiting.
- diarrhea. You may need to be treated with anti-diarrheal medicines.
- tiredness or weakness
- stomach area (abdominal) pain
- joint pain
- decreased appetite
- pain in arms or legs
These are not all of the possible side effects of Onureg. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the dosage for Onureg?
Important Administration Information
Do not substitute Onureg for intravenous or subcutaneous azacitidine. The indications and dosing regimen for Onureg differ from that of intravenous or subcutaneous azacitidine.
The recommended dosage of Onureg is 300 mg orally once daily with or without food on Days 1 through 14 of each 28-day cycle. Continue Onureg until disease progression or unacceptable toxicity.
If the absolute neutrophil count (ANC) is less than 0.5 Gi/L on Day 1 of a cycle, do not administer Onureg. Delay the start of the cycle until the ANC is 0.5 Gi/L or more.
Instruct patients on the following:
- Do not split, crush, or chew Onureg tablets.
- Take a dose about the same time each day.
- If a dose of Onureg is missed, or not taken at the usual time, take the dose as soon as possible on the same day, and resume the normal schedule the following day. Do not take 2 doses on the same day.
- If a dose is vomited, do not take another dose on the same day. Resume the normal schedule the following day.
Onureg is a hazardous drug. Follow applicable special handling and disposal procedures.1
Monitoring And Dosage Modifications For Adverse Reactions
Monitor complete blood count every other week for the first 2 cycles and prior to the start of each cycle thereafter. Increase monitoring to every other week for the 2 cycles after any dose reduction for myelosuppression.
The recommended dosage modifications for adverse reactions are provided in Table 1.
Table 1: Recommended Dosage Modifications for Adverse Reactions
|Adverse Reaction||Severity||Recommended Dosage Modification|
|Myelosuppression||Neutrophils less than 0.5 Gi/L on Cycle Day 1||Interrupt treatment. Resume at the same dose once neutrophils return to 0.5 Gi/L or higher.|
|Neutrophils less than 1 Gi/L with fever at anytime||First Occurrence|
|Platelets less than 50 Gi/L with bleeding||First Occurrence|
|Gastrointestinal Toxicity||Grade 3 or 4 Nausea or Vomiting|
|Grade 3 or 4 Diarrhea|
|Other Adverse Reactions||Grade 3 or 4|
Is Onureg safe to use while pregnant or breastfeeding?
- Based on its mechanism of action and findings in animals, Onureg can cause fetal harm when administered to a pregnant woman.
- There are no available data on Onureg use in pregnant women to evaluate for a drug-associated risk.
- There are no data regarding the presence of azacitidine in human milk or the effects on the breastfed child or milk production.
- Because of the potential for serious adverse reactions in the breastfed child, advise women not to breastfeed during treatment with Onureg and for 1 week after the last dose.
Latest Cancer News
Onureg is a prescription medicine used for continued treatment of adults with acute myeloid leukemia (AML) who had a first complete remission (CR) following intensive induction chemotherapy with or without recovery of your blood cell counts, and who are not able to complete intensive curative therapy.
Multimedia: Slideshows, Images & Quizzes
Leukemia Quiz: Test Your Medical IQ
What do you know about leukemia? Did you know there are different types? What are the symptoms? Take the Leukemia Quiz and test...
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
Blood Cancer Types: Leukemia, Lymphomas, Myelomas, and More
Types of blood cancers include leukemia, lymphomas, multiple myelomas, and others discussed in this slideshow. Symptoms may...
Related Disease Conditions
Leukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly speaking, leukemia should refer only to cancer of the white blood cells (the leukocytes) but in practice it can apply to malignancy of any cellular element in the blood or bone marrow, as in red cell leukemia (erythroleukemia).
Childhood Acute Lymphoblastic Leukemia (ALL)
Childhood acute lymphoblastic leukemia is the most common type of cancer in children. Symptoms and signs include fever, easy bruising, bone or joint pain, weakness, loss of appetite, and painless lumps in the neck, underarm, stomach, or groin. Treatment depends upon staging and may include chemotherapy, radiation, or stem cell transplant.
How Does Leukemia Kill?
Leukemia is a cancer of the white blood cells of the bone marrow. Patients with leukemia have an over-production of a particular blood cell type in the body, the white blood cells (cells that fight infection, and provide immunity).
What Is the Life Expectancy of a Person With Leukemia?
Leukemia is a group of cancers of the blood affecting the white blood cells. White blood cells are the infection-fighting cells of the body. In adults, leukemia is most common in people older than 55 years, with the average age of diagnosis being 66 years. It is also one of the most common cancers in children and adults younger than 20 years. The survival rate is higher for younger people.
Leukemia: Signs, Symptoms, And Complications
Leukemia results when the genetic material (DNA) of a single cell in the bone marrow transforms, this is called a mutation. A mutated cell does not perform body function, but it eats away the nutrition meant for the normal cells.
Treatment & Diagnosis
- Leukemia FAQs
- Evolution of Treatment for a Rare Type of Leukemia
- Gleevec and Chronic Myeloid Leukemia
- How Familes Cope with a Leukemia Diagnosis
- Coping with a Bad Disease - Community Counts
- A Family's Leukemia Diary - Coping
- Is Multiple Myeloma the Same as Leukemia?
- Does Folic Acid Prevent Leukemia?
- Can Folic Acid Prevent Leukemia?
- Chronic Myelogenous Leukemia (CML)
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.